Congenital and developmental myasthenia

G6_CONDEVMYA

Myasthenia gravis: Myasthenia gravis (MG) is a rare, clinically heterogeneous, autoimmune disorder of the neuromuscular junction characterized by fatigable weakness of voluntary muscles.

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 G70.20, G70.21, G70.28
Cause of death: ICD-10 G70.20, G70.21, G70.28

2 out of 7 registries used, show all original rules.

28

diagram downward connector

Check minimum number of events None

28

diagram downward connector

Include endpoints None

28

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

26

diagram downward connector
G6_CONDEVMYA

Control definitions

Control exclude G6_MYONEU

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 26 17 9
Unadjusted prevalence (%) 0.01 0.01 0.01
Mean age at first event (years) 49.67 43.27 61.75

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: G6_CONDEVMYA – Congenital and developmental myasthenia
GWS hits:

Survival analyses between endpoints

Plot

before Congenital and developmental myasthenia
after Congenital and developmental myasthenia

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Congenital and developmental myasthenia

Endpoint not on priority list, no data to show.